Zepbound vs Mounjaro: When the Same Drug Has Two Brand Names
Zepbound and Mounjaro are identical molecules (tirzepatide) made by Eli Lilly. Mounjaro is FDA-approved for type 2 diabetes; Zepbound is approved for chronic weight management. Insurance coverage is the most likely deciding factor.
If Wegovy is to Ozempic what Zepbound is to Mounjaro: same drug, two labels, regulatory and insurance reasons for the split.
The molecule
Both are tirzepatide, manufactured by Eli Lilly. Same dose strengths (2.5, 5, 7.5, 10, 12.5, 15 mg). Same titration schedule. Same once-weekly subcutaneous injection.
Why two brands exist
Eli Lilly first won FDA approval for tirzepatide as a type 2 diabetes drug in 2022 under the brand name Mounjaro. The clinical trial program for obesity (SURMOUNT-1, SURMOUNT-2) finished a year later, and in late 2023 the FDA approved tirzepatide for chronic weight management under the brand name Zepbound.
The reason for two brand names is purely commercial: it lets Lilly negotiate different prices and rebates with insurers depending on the indication.
What is different in practice
| Zepbound | Mounjaro | |
|---|---|---|
| Molecule | Tirzepatide | Tirzepatide |
| FDA approval | Chronic weight management | Type 2 diabetes |
| Insurance coverage | Often covered for BMI ≥30 (or ≥27 with comorbidity) | Often covered for diabetes only |
| List price | Slightly different | Slightly different |
| Pen design | Identical mechanism | Identical mechanism |
That is essentially the entire list. The molecule is the same, the side-effect profile is the same, the muscle-loss risk is the same, and the protein floor you need to hit on either one is the same.
When patients switch
Patients commonly switch between the two when:
- Insurance coverage changes
- A diabetic loses enough weight that their HbA1c normalizes (and Mounjaro coverage gets reviewed)
- Local pharmacy supply favors one brand over the other
The transition is seamless: your prescriber writes for the equivalent dose strength on the new pen, and you continue.
Bottom line
If you have a choice, take whichever your insurance covers. If you are paying out of pocket, both list-price equivalents land in roughly the same range, and Lilly's direct-pay programs (LillyDirect) often offer the best out-of-pocket price on Zepbound. The clinical experience is identical.